

Navigating Market Access -
A Primer for Life Science Executives

NAVIGATING MARKET ACCESS
Navigate the complexities of market access and commercialization seamlessly with our downloadable strategic resource. Designed to support your early considerations, this market access primer provides a nuanced understanding of the interplay between your clinical development decisions and the subsequent assessment of your drug’s value by regulators, payers, patients, and healthcare providers.
Using the primer will help you make informed choices that resonate throughout the product lifecycle. Whether anticipating regulatory scrutiny, understanding payer perspectives, or aligning with patient and provider needs, our the market access primer will empower you to navigate the intricate landscape of drug development with foresight and strategic precision.

OVERVIEW
TABLE OF CONTENTS
This primer is a concise guide to market access, covering essential aspects of bringing new drugs to market, including demonstrating societal value, affordability, and worth to healthcare stakeholdlers. Topics include health technology assessments, pricing, reimbursment pathways, and regulatory factors. While not exhaustive, it serves as a roadmap to help optimize drug launches, substatatiate asset value, and ultimately gain successful market penetration and commerical success.
For life science executives, understanding market access is crucial for optimizing asset strategies and achieving successful drug launches. This primer provides valuable insights into navigating the complexities of the pharmaceutical landscape, equipping leaders with the knowledge needed to make informed decisions. By grasping key concepts outline in this guide, executives can enhance their strategic approach, mitigate risks, and maximize opportunities for market penetration and commercial success.

Pricing: Introduction to the Concept of Drug Pricing

Reimbursement: Understanding the Payer Landscape

Contracting, Negotiations, and Stakeholder Management: Value-based Contracting and More...

Health Economics and Policy: Clearing the Fourth Hurdle of Drug Development

Case Studies

PURCHASE OPTIONS
Note: Prices are net. The deck is current as of December 2024 and will be updated annually to ensure the most relevant insights.
If you decide to engage in a consulting project following the purchase of this primer, the fee paid for the deck will be deducted from the cost of the consulting engagement.
